Comparative efficacy of various exercise types and doses for quality of life in patients with heart failure: a network and dose-response meta-analysis

不同运动类型和剂量对心力衰竭患者生活质量的比较疗效:一项网络和剂量反应荟萃分析

阅读:3

Abstract

BACKGROUND: Heart failure (HF) significantly compromises quality of life (QoL). Although exercise interventions are a well-established strategy for improving QoL in patients with HF, the efficacy of various exercise modalities and effective doses remains unclear. This study aims to ascertain the efficacy of different exercise modalities and their relative doses in optimizing QoL in patients with HF. METHODS: This systematic review and network meta-analysis searched PubMed, Web of Science, Embase, MEDLINE, and Cochrane databases. Randomized controlled trials (RCTs) involving exercise interventions were included. Data on dose metrics (METs-min/week), treatment regimens, exercise intensity, and study duration were extracted and analyzed. RESULTS: Thirty RCTs involving 1,780 participants were included in the review. High-intensity interval training (HIIT), combined aerobic and resistance training (CT), mind-body exercise (MBE), and resistance training (RT) all demonstrated substantial efficacy in improving QoL compared with the control group (SMD = -0.59, -0.57, -0.58, and -0.57; SUCRA: 64.8%, 63.9%, 62.1%, and 62%, respectively). The optimal doses were approximately 750, 1,000, 390, and 490 METs-min/week for HIIT, CT, MBE, and RT, respectively. While aerobic exercise (AE) also demonstrated efficacy, the observed therapeutic benefit was modest. CONCLUSION: HIIT, CT, MBE, and RT exhibit strong and comparable efficacy in improving QoL in patients with HF, whereas AE offers a more modest benefit. MBE demonstrates efficacy at relatively low doses, while CT and HIIT yield progressive improvements with increasing doses. SYSTEMATIC REVIEW REGISTRATION: https://www.crd.york.ac.uk/PROSPERO/view/CRD420251181909, PROSPERO CRD420251181909.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。